ConductScience.org, home

Trial · NCT01475955

Registered outcomes70

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryComplete Clearance RateWeek 12The proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area
SecondaryComplete Clearance RateWeek 4The proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area
SecondaryComplete Clearance RateWeek 8The proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area
SecondaryComplete Clearance RateWeek 24the proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area
SecondaryPartial Clearance RateBaseline, Week 4proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.
SecondaryPartial Clearance RateBaseline, Week 8proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.
SecondaryPartial Clearance RateBaseline, Week 12proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.
SecondaryPartial Clearance RateBaseline Week 24proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.
SecondaryAK Clearance RateBaseline, Week 4AK Clearance Rate (AKCR) for a subject is defined as: 100% x \[1 - (Number of AK lesions in the Treatment Area at follow-up visit/Number of AK lesions in the Treatment Area at Baseline)\]
SecondaryAK Clearance RateBaseline, Week 8AK Clearance Rate (AKCR) for a subject is defined as: 100% x \[1 - (Number of AK lesions in the Treatment Area at follow-up visit/Number of AK lesions in the Treatment Area at Baseline)\]
SecondaryAK Clearance RateBaseline, Week 12AK Clearance Rate (AKCR) for a subject is defined as: 100% x \[1 - (Number of AK lesions in the Treatment Area at follow-up visit/Number of AK lesions in the Treatment Area at Baseline)\]
SecondaryAK Clearance RateBaseline, Week 24AK Clearance Rate (AKCR) for a subject is defined as: 100% x \[1 - (Number of AK lesions in the Treatment Area at follow-up visit/Number of AK lesions in the Treatment Area at Baseline)\]
SecondarySubject Satisfaction ScoreWeek 240 = no improvement or worsening (not satisfied at all) 1. = slight improvement (slightly satisfied) 2. = moderate improvement (moderately satisfied) 3. = excellent improvement (very satisfied)
SecondaryHyperpigmentation at BaselineBaseline
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
SecondaryHyperpigmentation at Visit 224-48 Hours after PDT #1
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
SecondaryHyperpigmentation at Visit 3Week 2
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
SecondaryHyperpigmentation at Visit 4Week 4
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
SecondaryHyperpigmentation at Visit 5Week 8
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
SecondaryHyperpigmentation at Visit 6Week 12
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
SecondaryHyperpigmentation at Visit 7Week 24
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01475955/registered